Rowley Law Investigates XOMA Royalty Corporation Acquisition Concerns

Investigation Overview

Rowley Law PLLC has recently initiated an investigation into XOMA Royalty Corporation (NASDAQ: XOMA) amidst concerns regarding possible securities law violations arising from the proposed acquisition of the company by Ligand Pharmaceuticals Incorporated (NASDAQ: LGND). This announcement was made on April 27, 2026, and reveals critical details about the acquisition that could affect shareholders significantly.

Details of the Acquisition

The proposed acquisition entails stockholders of XOMA Royalty receiving $39.00 for each share they possess, as well as one contingent value right. The entire deal is estimated to be worth around $739 million and is projected to conclude in the third quarter of 2026. Ligand Pharmaceuticals, a company with a strong portfolio, aims to solidify its position in the biotechnology and pharmaceutical sectors via this acquisition.

Investigative Focus

Rowley Law PLLC is particularly concerned about the conduct of XOMA's board of directors in light of the acquisition. They are exploring whether there have been any breaches of fiduciary duty or security law violations that have negatively impacted shareholders. This investigation highlights the importance of transparency and responsibility among corporate boards, particularly during significant transitions like acquisitions and mergers.

Investors are urged to stay informed about the developments related to this investigation and the acquisition process. Shareholders of XOMA Royalty Corporation are encouraged to take an active role in monitoring their investments and to reach out for more information if they feel their interests are not being adequately protected.

How to Get Involved

If you hold shares in XOMA Royalty Corporation and wish to learn more regarding this investigation or discuss potential options, Rowley Law PLLC invites you to visit their website at http://www.rowleylawpllc.com/investigation/xoma/. You may also directly contact Shane Rowley, Esq. at their White Plains office—located at 50 Main Street, Suite 1000, White Plains, NY 10606. Reach out via email at [email protected] or call 914-400-1920 or 844-400-4643 (toll-free).

The Role of Rowley Law PLLC

Rowley Law PLLC is a firm that specializes in representing shareholders in class actions and derivative lawsuits related to complex corporate litigation. They have established a reputation for advocating vigorously for the rights of investors across a variety of sectors. As they investigate the matter at hand, they will be working diligently to ensure that shareholders of XOMA Royalty Corporation are kept informed and represented in any proceedings that may arise from this situation.

Final Thoughts

The acquisition of XOMA Royalty Corporation by Ligand Pharmaceuticals presents significant potential for both companies involved. However, it’s paramount that shareholders remain vigilant regarding the actions taken by XOMA's board. By engaging with legal experts and following up on developments, investors can better secure their financial interests during this crucial time.